Volitionrx (VNRX) Total Liabilities (2011 - 2025)

Volitionrx has reported Total Liabilities for 12 years, with the latest figure at $42.5 million in Q4 2025.

• For the quarter ending Q4 2025, Total Liabilities rose 19.68% year-over-year to $42.5 million; the trailing twelve-month figure through Dec 2025 stood at $42.5 million (up 19.68% YoY), and the FY2025 full-year result was $42.5 million, up 19.68% from the prior year.
• Total Liabilities for Q4 2025 stood at $42.5 million, roughly flat from $42.4 million in the prior quarter.
• The five-year high for Total Liabilities was $42.5 million in Q4 2025, with the low at -$31.2 million in Q1 2021.
• Historically, Total Liabilities has averaged $24.4 million across 5 years, with a median of $21.9 million in 2022.
• Annual changes were most pronounced in 2021 — Total Liabilities plunged 505.26% — and 2022, when it surged 166.98%.
• Volitionrx's Total Liabilities stood at $9.8 million in 2021, then surged by 119.3% to $21.4 million in 2022, then surged by 71.15% to $36.7 million in 2023, then declined by 3.15% to $35.5 million in 2024, then grew by 19.68% to $42.5 million in 2025.
• The last three Total Liabilities figures came in at $42.5 million (Q4 2025), $42.4 million (Q3 2025), and $41.8 million (Q2 2025), per Business Quant data.